NYSE · ABT
Abbott Laboratories
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for ABT has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $1.64 | $1.65 | $1.63 | 8 |
| Mar 2027 | $1.23 | $1.25 | $1.21 | 5 |
| Jun 2027 | $1.44 | $1.47 | $1.42 | 5 |
| Sep 2027 | $1.54 | $1.59 | $1.51 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · BNK Invest · Zacks · The Motley Fool- RTTNews · Oct 29, 3:58 AM EDTTarsus Names Neera Clase Commercial Chief To Expand XDEMVY Reach And Lead Pipeline Planning(RTTNews) – Wednesday, Tarsus Pharmaceuticals, Inc. (TARS) said it has appointed Neera Clase as Chief Commercial Officer (CCO), effective November 1, 2026.
- BNK Invest · Oct 28, 10:58 AM EDTSCHD, COP, CVX, ABT: ETF Inflow AlertLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Dividend Equity ETF (Symbol: SCHD) where we have detected an approximate $814.8 million dollar inflow — that's a 0.7% increase week over w
- Zacks · Oct 27, 8:30 AM EDTIs Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
- Zacks · Oct 27, 8:00 AM EDTIs Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now?Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- The Motley Fool · Oct 26, 2:18 PM EDTThis Dividend King Just Announced Great News for InvestorsAbbott Laboratories’ third-quarter results were somewhat mixed, with the company’s nutrition business still dragging down sales growth.
- RTTNews · Oct 26, 11:01 AM EDTAbbott Launches Next-Generation Oncodetect Test For Cancer Residual Disease Detection(RTTNews) – Monday, Abbott Laboratories (ABT), a global healthcare company, announced the commercial availability of its next-generation Oncodetect molecular residual disease (MRD) test, designed to detect traces of cancer during and after treatment.
- The Motley Fool · Oct 24, 1:31 PM EDTAbbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?Abbott Laboratories maintains a highly diversified healthcare business spanning medical technology, diagnostics, and nutrition.
- RTTNews · Oct 23, 10:53 AM EDTWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win(RTTNews) – Healthcare and biotech news this week centred on regulatory approvals, strategic deals, and pivotal clinical data.
- RTTNews · Oct 23, 10:18 AM EDTAbbott's Oncodetect Test Shows 30%-Point Sensitivity Gain In Colorectal Cancer Study(RTTNews) – On Friday, Abbott (ABT) said its whole-genome sequencing-based Oncodetect test showed a 30-percentage-point improvement in sensitivity for colorectal cancer recurrence within two years of surgery compared with its whole-exome sequencing test.
- MarketBeat · Oct 23, 7:25 AM EDT3 Stocks With Yields Big Enough to Make Election Volatility Easier to StomachElection season has a way of making portfolios feel more fragile than they are. Polls point one direction, betting markets point another, and stocks swing on every headline about who controls Congress next. That anxiety tends to push investors toward positioning for an outcome n
- Barchart · Oct 22, 1:55 PM EDTStocks Rally on Positive AI News, with SpaceX up +7%The S&P 500 Index ($SPX ) (SPY ) rose +0.59% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) rose +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +1.13%. December E-mini S&P futures (ESZ26 ) rose +0.62%, and December E-mini Nasdaq futures (NQZ26 ) rose…
- MarketBeat · Oct 22, 11:00 AM EDTCologuard Is Working—So Why Isn’t Abbott Stock?Abbott Laboratories (NYSE: ABT) delivered its third-quarter earnings report on Oct. 21. The stock dropped about 4% in early trading, as the results were merely solid, at a time when investors wanted something spectacular. Revenue of $13.01 billion edged out expectations for $12
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Abbott Laboratories from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.